Author

Christopher Liddle

The University of SydneyORCID 0000-0003-3936-6790Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Assay:ChIP-seq· 1 Research Focus:differential expression· 1 Assay:DNA methylation· 1

Frequent Co-Authors

Andrew M. LowyiD· 1 shared Annette R. AtkinsiD· 1 shared Brian GlossiD· 1 shared Catherine L. WorthiD· 1 shared Daniel Y. Cao· 1 shared Daniele VitaleiD· 1 shared Dannielle D. EngleiD· 1 shared Duncan J. McLeodiD· 1 shared

Activity by Year

2022-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Andrew M. LowyORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyProceedings of the National Academy of SciencesPeer-reviewedJun 25, 2026

HDAC Inhibition Sensitizes Pancreatic Tumors to DNA Damage by Global Redistribution of the Transcriptional Machinery

Gaoyang Liang, Hung V.‐T. Nguyen, Jonathan Zhu…·Ronald M. Evans

This study shows HDAC inhibition reduces DDR gene expression in pancreatic tumors by altering transcriptional machinery distribution, enhancing sensitivity to DNA damage, and introduces a nanoparticle delivery system to reduce toxicity.

DOI 10.1073/pnas.2536040123

humanDNA methylation

𝕏 PostBluesky

Cancer BiologybioRxivPreprintApr 16, 2022

Higher basal tumor immune activity coupled with a systemic immune response improves liver cancer outcomes

Ghazal Alipour Talesh, Daniele Vitale, Peter Langfelder…·Saeed Esmaili

The paper shows that stronger systemic and liver immune responses improve liver cancer outcomes by reducing tumor burden and correlating with better survival.

1 citation

humanmouse

𝕏 PostBluesky